Fabrice Vallée, MD; Joaquim Mateo, MD; Guillaume Dubreuil, MD; Thomas Poussant, MD ;
Guillaume Tachon , MD ; Ingrid Ouanounou , MD ; and Didier Payen , MD, PhD

Jukka Takala, MD, PhD

Gerasimos S. Filippatos1*, Mustafa I. Ahmed2, James D. Gladden2, Marjan Mujib2,
Inmaculada B. Aban2, Thomas E. Love3, Paul W. Sanders2,4, Bertram Pitt5,
Stefan D. Anker6,7, and Ali Ahmed2,4

Dolly Aguilera a Tadanori Tomita b, d Stewart Goldman c, d Jason Fangusaro c, d

JOURNAL OF CLINICAL ONCOLOGY

JOURNAL OF CLINICAL ONCOLOGY

Emmanuelle di Tomaso1,6, Matija Snuderl2, Walid S. Kamoun1, Dan G. Duda1, Pavan K. Auluck2, Ladan Fazlollahi2,
Ovidiu C. Andronesi3, Matthew P. Frosch2, Patrick Y. Wen4, Scott R. Plotkin5, E. Tessa Hedley-Whyte2,
A. Gregory Sorensen3, Tracy T. Batchelor5, and Rakesh K. Jain1

Jo Waaler1, Ondrej Machon1,4, Jens Peter von Kries5, Steven Ray Wilson2, Elsa Lundenes2,
Doris Wedlich6, Dietmar Gradl6, Jan Erik Paulsen3, Olga Machonova1, Jennifer L. Dembinski1,
Huyen Dinh1, and Stefan Krauss1

JB Baker*,1, D Dutta1, D Watson1, T Maddala1, BM Munneke1, S Shak1, EK Rowinsky2, L-A Xu3, CT Harbison3,
EA Clark3, DJ Mauro3 and S Khambata-Ford3

DH Brewster*,1, DI Clark1, DL Stockton1, AJ Munro2 and RJC Steele2